Gianna Melillo

New data to be presented at the American Academy of Ophthalmology’s Annual Meeting highlight the efficacy of Tepezza (teprotumumab), the first and only FDA approved medicine for thyroid eye disease.

Patients with chronic migraine who received a combination therapy of erenumab and onabotulinumtoxinA exhibited significant reductions in monthly headache days and monthly migraine days.

Serum fatty acid–binding protein 4 levels were increased in patients with heart failure with preserved ejection fraction (HFpEF), associated with cardiac remodeling and dysfunction, and linked to poor outcomes.

New data show combining glucagon-like peptide-1 receptor agonist (GLP-1 RA) exenatide plus sodium–glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin remains effective after 2 years for type 2 diabetes (T2D) uncontrolled with metformin.

New results from the phase 3 ULTIMATE trial show Novartis’ Cosentyx (secukinumab) demonstrated significant treatment response on synovitis in patients with active psoriatic arthritis (PsA) compared with placebo.

Central retinal vessel density is associated with diabetic retinopathy severity in eyes without, but not with, predominantly peripheral lesions (PPL) according to a study published in JAMA Ophthalmology.

Although a winner has yet to be declared in the 2020 presidential race, several ballot measures and state level races yielded results with major implications in the health care field. Below is a list of the most influential health care–related outcomes of the 2020 elections.

Older Americans with vision impairment may be less likely to use cancer-related preventive services compared with their counterparts without vision impairment.

Variability in prevalence of vestibular migraine, depending on ethnicity and geographic location suggests, a combined genetic and environmental contribution to VM, according to results of a systematic review.

A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.

This week, CMS proposed changes to the Medicare Durable Medical Equipment Prosthetics, Orthic Devices and Supplies (DMEPOS) coverage and payment policies which would expand Medicare coverage for continuous glucose monitors (CGMs).

Results from a prespecified ancillary study show neither vitamin D3 nor marine ω-3 fatty acid supplementation had a significant overall effect on age-related macular degeneration (AMD) incidence or progression.

At the Alliance for Better Health’s CONVERGE Virtual Conference, experts discussed the role social determinants of health (SDOH) play in community-based health initiatives.

In severely obese patients with previous myocardial infarction, metabolic surgery was associated with a lower risk of heart attack and new onset heart failure, according to study results published in Circulation.

In a study published in Scientific Reports, researchers highlighted structural and functional brain differences among those who suffer menstrual-related migraine (MRM) and pure menstrual migraine (PMM).

In a longitudinal cohort study, researchers identified 17 seemingly novel variants of the PDE6A retinitis pigmentosa gene, suggesting it may be amenable to gene therapy.

Experts presenting the American Society of Nephrology’s Kidney Week session entitled “From Kids to Adults: Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Across the Life Course,” outlined the detrimental effects of childhood CKD and other kidney diseases on long-term health.

In a session focused on sodium-glucose cotransporter 2 (SGLT2) inhibitors presented at the American Society of Nephrology’s (ASN) Kidney Week, experts highlighted the benefits of using this drug class in patients with kidney disease and outlined future steps for integration of care.

Consuming more green tea and coffee was associated with reduced all-cause mortality among individuals with type 2 diabetes (T2D), according to the results of a prospective study published in BMJ Open Diabetes Research and Care.

Anti–vascular endothelial growth factor (VEGF) treatment was associated with preserved useful visual acuity in almost 20% of patients with neovascular age-related macular degeneration (nAMD).

Data from a 5-year open-label treatment period on the safety profile of erenumab (Aimovig) showed the treatment helped patients with episodic migraine achieve a sustained reduction in the number of monthly migraine days and the number of days in which therapies were needed for acute migraines.

Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.

Although probing for congenital nasolacrimal duct obstruction is safe and effective , age at the time of initial intervention and bilateral surgery constitutes a significant risk for a failed procedure, according to study results published in BMC Ophthalmology.

New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.

Acute coronary syndrome (ACS) was associated with lower inner vessel length density, measured via optical coherence tomography angiography (OCT-A), and with higher concentrations of angiopoietin-2 and osteoprotegerin, according to study results published in Scientific Reports.

Migraine is a significant risk factor for postoperative nausea and vomiting, according to results of a retrospective study published in the Journal of Clinical Medicine.

Compared with placebo, low-dose atropine (0.01%) eyedrops may slow myopia (nearsightedness) progression and axial elongation in Chinese children with low and moderate myopia.

Patients who received anti-inflammasome nucleoside reverse-transcriptase inhibitors (NRTIs)—drugs approved to treat HIV-1 and hepatitis B infections—exhibited a 33% reduced risk of developing type 2 diabetes (T2D), according to a meta-analysis published in Nature Communications.

The Trump administration signed a $486 million agreement with AstraZeneca to develop a coronavirus disease 2019 (COVID-19) antibody treatment.

Researchers found the nucleocapsid protein (NP) antigen of SARS-CoV-2, the virus which causes coronavirus disease 2019 (COVID-19), existed intracellularly in the ocular tissues of a patient who previously had COVID-19.